Arcalyst (Regeneron Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Arcalyst drug offered from Regeneron Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Regeneron Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | rilonacept |
| SUBSTANCE NAME: | RILONACEPT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2008-02-27 |
| END MARKETING DATE: | 0000-00-00 |
Arcalyst HUMAN PRESCRIPTION DRUG Details:
| Item Description | Arcalyst from Regeneron Pharmaceuticals, Inc. |
| LABELER NAME: | Regeneron Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 160(mg/2mL) |
| START MARKETING DATE: | 2008-02-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61755-001_affea015-5d74-46f4-b85e-d647d08268c0 |
| PRODUCT NDC: | 61755-001 |
| APPLICATION NUMBER: | BLA125249 |
Other RILONACEPT Pharmaceutical Manufacturers / Labelers:
